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Abstract
Lipoxygenases (LOX) play pivotal roles in the biosynthesis of leukotrienes and other biologically
active eicosanoids derived from arachidonic acid. A mechanistic understanding of substrate
recognition, when lipoxygenases that recognize the same substrate generate different products, can
be used to help guide the design of enzyme-specific inhibitors. We report here the 1.85 Å
resolution structure of an 8R-lipoxygenase from Plexaura homomalla, an enzyme with ~40%
sequence identity to human 5-LOX. The structure reveals a U-shaped channel, defined by
invariant amino acids, that would allow substrate access to the catalytic iron. We demonstrate that
mutations within the channel significantly impact enzyme activity and propose a novel model for
substrate binding potentially applicable to other members of this enzyme family.
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Lipoxygenases are non-heme iron dioxygenases that catalyze the stereo- and regio- specific
formation of fatty acid hydroperoxides from polyunsaturated fatty acids (1, 2). In animals,
lipoxygenases (LOX) play pivotal roles in the biosynthesis of leukotrienes and other
biologically active eicosanoids derived from arachidonic acid (AA). Consequently, the
enzymes are targets for the development of specific inhibitors to modulate the physiological
and pathological effects of the potent signaling compounds they generate (3, 4). Since
lipoxygenases are iron enzymes they can be inhibited by iron chelators or redox active
compounds. However, these modes of inhibition are inherently non-specific. In order to
engineer specificity into any inhibitor, more structural information for this enzyme family is
required. Yet no LOX structure provides a comprehensive model for how substrate binds in
the active site, a model central to the development of isozyme-specific inhibitors. A
mechanistic understanding of substrate recognition, when lipoxygenases that recognize the
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same substrate discriminate among the three chemically equivalent carbons of arachidonic
acid to generate different products, can be used to help guide the design of novel inhibitors.
Work with the plant enzymes has afforded tremendous insight into the mechanism of
hydrogen abstraction by the active site iron, but the basis for the specificity of oxygenation
in LOX catalysis is still unclear (5).
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We report here the 1.85 Å resolution structure of an 8R-lipoxygenase from Plexaura
homomalla, an enzyme that, like human LOX isoforms, has ~40% sequence identity to
human 5-LOX, the enzyme that initiates leukotriene biosynthesis. The structure reveals a Ushaped channel, defined by invariant isoleucines and leucines, that allows substrate access to
the catalytic iron. We demonstrate that mutations within this channel significantly impact
enzyme activity. Based on our results we propose a model for substrate binding in which an
invariant Leu points into the U-shaped channel and restrains the targeted pentadiene for
hydrogen abstraction. The register of the pentadiene positioned for attack is set by proteinsubstrate interactions at either end of the U-shaped channel.
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The features of an 8R-LOX binding site must be able to account for the regio- and stereospecificity of the enzyme, yet exhibit the potential flexibility to explain the range of
specificities found within the LOX enzyme superfamily. Consequently, the model must be
compatible with several well-established aspects of LOX catalysis. (i) The non-heme iron,
positioned by amino acids that fill five of the six sites of the coordination sphere, interacts
with the substrate via its sixth position as Fe3+-OH. Sequence, structural and biochemical
data suggest that the geometry of the catalytic machinery is conserved among LOX
enzymes. (ii) Fe3+-OH initiates catalysis by stereoselective removal of one hydrogen from
the CH2 in a cis- CH2-cis double bond unit (pentadiene) of the substrate. The free radical
pentadiene intermediate generated by H abstraction is oxygenated on its opposite face, at
one of two possible positions: the +2 or −2 carbon. Reaction at the +2 or −2 positions yields
products of opposite stereochemistry (R or S) (Fig 1). (iii) A conserved active site Gly in RLOX is associated with R oxygenation. Its counterpart in S-LOX is Ala. A Gly/Ala switch
by mutagenesis redirects oxygenation across the face of the pentadiene, changing the
positional specificity along with R or S stereochemistry. (iv) The fatty acid substrate is held
in one head-to-tail orientation or the other. While four distinct hydroperoxide products can
arise from each pentadiene in the substrate, each LOX generates only a single specific
product. For example, LOX catalyzed peroxidation of the central pentadiene of arachidonic
acid requires hydrogen abstraction at C10 and could potentially generate 8R or 12S with AA
bound in one orientation, and 8S or 12R if AA binds in the inverse orientation (Fig. 1). For
the enzyme described herein, only the 8R-product is observed. (v) Finally, some
lipoxygenases produce the identical hydroperoxide product from free arachidonic or linoleic
acids or their large esters (e.g. phospholipid esters). This implies that the carboxyl group
does not enter the active site, thus the binding orientation for these enzymes (e.g. 15S-LOX)
has generally been designated as “tail-first” into the active site. In contrast, the 5S-, 8S or
12R- enzymes cannot oxygenate the phospholipid esters, and their product specificities can
be explained by “head first” entry into the active site. There are, however, notable
exceptions to this last rule which require a rational explanation as we discuss later.
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In effect, active site control of LOX product specificity is determined by three factors: which
pentadiene of the substrate is positioned for attack, whether the proR or proS hydrogen of
the pentadiene is positioned for abstraction, and whether O2 has access to carbon C−2 or
C+2. Our model provides a structural framework to understand the determinants of product
diversity of lipoxygenases.

MATERIALS AND METHODS
Protein crystallizations

Author Manuscript

A deletion mutant of Plexaura homomalla 8R-LOX engineered for improved solubility,
referred to herein as pseudo wild-type (pSWT), was concentrated to ~10 mg/ml and
crystallized by sitting-drop vapor-diffusion as previously reported(6). The I433W and I433A
mutants of psWT were constructed using whole plasmid polymerase chain reaction. Crystals
of I433W:psWT and I433A:psWT were obtained by sitting drop vapor diffusion in 5-8%
PEG-8000, 5% glycerol, 0.2 M CaCl2, 0.1 M imidazole acetate, pH 8.0. Crystallizations
were performed in a Coy anaerobic chamber. The crystals, which grow overnight, were
mounted using a cryo-protecting solution of 10% PEG-8000, 25% glycerol, 0.02 M CaCl2,
0.1 M imidazole acetate, pH 8.0.
X-ray data collection and structure determination
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X-ray diffraction data (psWT, I433W:psWT; I433A:psWT) were collected at the Gulf Coast
Protein Crystallography Consortium beamline at the Center for Advanced Microstructures
and Devices (CAMD, Louisiana State University) using 1.38 Å radiation at a temperature of
100 K. Data for psWT, I433W:psWT and I433A:psWT were processed to a resolution of
1.85 Å, 1.9 Å, and 2.3 Å, respectively (Table 1), using the HKL2000 package(7). The
structure of psWT was solved by molecular replacement using the previously published 3.2
Å structure of coral 8R-lipoxygenase (PDB: 2FNQ)(8). The two mutant structures were
solved by using only the protein atoms from the refined parent structure as a starting model,
refining the protein model and adding ions, small molecules, and waters. Model building
was done with Coot(9) and refinement with REFMAC5 (10)and Phenix(11). Model quality
was assessed using MolProbity(12). For the psWT structure, 97% of the residues are in the
favored region of the Ramachandran plot, with only a single residue outside the allowed
region out of 2800 total residues (there are four molecules in the asymmetric unit). The
I433W:psWT structure had 96.9% of the residues in the favored region of the
Ramachandran plot, with only 1 outside the allowed region out of 2810 residues. The
I433A:psWT structure had 96.7% of the residues in the favored region of the Ramachandran
plot, with 4 residues outside the allowed region out of 2758 residues.
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Enzyme kinetics
The LOX activity assay of 8R-LOX wild-type and mutants was carried out in a 1 ml sample
volume (in 50 mM Tris buffer, pH 7.5, 150 mM NaCl) by following the absorbance increase
at 235 nm due to the formation of conjugated diene chromophore using a Lambda 35
UV/Vis spectrophotometer (PerkinElmer). The concentration of wild-type enzyme was 12.5
nm; for the less active mutants enzyme concentrations were increased up to 63 nm. Substrate
concentration was varied from 10-200 μM. The rates of reaction were calculated from the
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initial linear part of the curve. Values for Km and turnover were determined by nonlinear
regression analysis of a plot of velocity versus substrate concentration data to the MichaelisMenten equation. Activity fro the I433A:psWT enzyme was only measurable in the presence
of detergent and CaCl2 (50 mM Tris, pH 7.5, 500 mM NaCl, 0,05% emolphogen, 2 mM
CaCl2).
Product Analysis

Author Manuscript

8R-lipoxygenase mutagenesis was performed using the Stratagene® Quickchange
Mutagenesis kit according to the manufacturer's instructions to replace Leu-432 with Ala,
Val, Ile or Phe. Expression and purification of wild-type, psWT, and all mutants for product
analysis was performed as reported by Boutard et al. (13). Protein was quantified by running
on a 20-4% polyacrylamide gel along with a series of known amounts (1-10 ug) of BSA as
previously described (14). Incubations were carried out in 50 mM Tris pH 8.0 containing
500 mM NaCl, 2 mM CaCl2, and 0.05% Emulphogen (Sigma) with 50 μM Arachidonic
Acid containing 5×105 cpm of [1-14C]arachidonic acid. Samples were incubated for 10 min
at room temperature (with shaking) and subsequently extracted with a Waters 1cc Oasis
HLB cartridge and eluted with 1ml of methanol. Treatment with triphenylphosphine in
methanol at room temperature for 10 minutes was performed to reduce the
hydroperoxyeicosatetraenoic acids (HPETEs) to their hydroxy counterparts (HETEs).
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Samples were analyzed initially by RP-HPLC using a Waters Symmetry C18 column (250 ×
4.6 mm) with a solvent system of methanol/water/glacial acetic acid (80:20:0.01, by
volume) running at 1ml/min. The eluant was monitored with an Agilent 1100 diode array
detector in series with a Radiomatic Flo-One/Beta A100 inline scintillation counter. This
allowed determination of the conversion of substrate to H(P)ETEs (8- and 12-HETE are not
well resolved on this system; they elute close together, partly resolved with 12- eluting
before 8-HETE). The samples were then methylated using diazomethane and the relative
amounts of the individual HETE methyl esters (8- and 12-HETE) were determined on
normal phase HPLC using a Beckman Ultrasphere Si column 4.6×250 mm in hexane/
isopropanol (100:1, v/v) at 1 ml/min. The chirality of the 8-HETE and 12-HETE methyl
ester products were analyzed using a Chiralpak AD column (250 × 4.6 mm) using hexane/
methanol solvent (100:2, v/v) at 1 ml/min (15)

RESULTS
High resolution 8R-LOX structure
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8R-LOX crystals diffracting to 1.85Å were obtained following modifications to a putative
membrane insertion loop and calcium-binding sites as detailed elsewhere(6). The modified
protein crystallized in space group P21 with four molecules in the asymmetric unit. The
structure of the mutant protein (Fig 2.) confirmed the supposition that removal of the
putative membrane insertion loop and calcium binding amino acids has no structural
consequences outside the immediate vicinity of the deletion. Lipoxygenases contain an Nterminal C2-like domain (~110 amino acids) and a predominately helical domain (~550
amino acids in animal lipoxygenases) in which the catalytic Fe is ligated by amino acid side
chains and the main-chain carboxylate of the C-terminal amino acid. 8R-LOX has three
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Ca2+ binding sites flanked by putative membrane insertion loops in the C2-like domain and
the deletion mutant used in these studies lacks one of the loops, as well as chelating amino
acids from two of the three Ca2+ binding sites (the center site and that most distal to the
catalytic domain). The Ca2+ site proximal to the catalytic domain, defined primarily by main
chain contacts, remains intact and occupied in the mutant structure. Additional density
which may be a Ca2+ ion is associated with E52, but the coordination sphere of the hepta
coordinated ion contains only two protein atoms, and these from different molecules, and is
not likely a biologically relevant interaction. Ca2+ promotes the binding of 8R-LOX to
membranes (8). The deletion mutant displays wild-type activity in a membrane-free assay,
however, Ca2+ does not promote membrane binding of the mutant and does not stimulate
enzyme activity in a membrane-based assay. Thus we refer to this enzyme as pseudo wildtype (psWT) in accordance with its native-like structure and catalytic activity in the absence
of membranes.

Author Manuscript

The structure reveals a channel with conserved features

Author Manuscript

A striking feature of the electron density map obtained for psWT is a U-shaped channel,
open at both ends, which runs under an arched helix and allows access to the catalytic iron
from two directions. The channel is a culvert which runs underneath the arch provided by
the curvature of α9, roughly orthogonal to it (Fig. 2). At the apex of the arch, sheltering the
culvert, is the helical turn that includes residues 428-432. From this turn, the side chain of
L432 points down into the U-shaped channel. At the base of this U-shaped channel sits the
catalytic iron. This arched, or discontinuous, helix (in P. homomalla α9-10, Fig. S1) is
found in all available lipoxygenase structures(16-21). The discontinuity is a consequence of
a reverse turn insertion previously discussed by Minor et. al. (17). The insertion, which
corresponds to the highly conserved glycine (Fig. 3) in animal and plant LOX, has the effect
of creating a long, curved helix that arches away from the bundle of helices that constitute
the catalytic domain. The C-terminal end of the helix is anchored to the LOX body by a salt
link between R429 on α9 and E394 on α7 (8R-LOX numbering, Fig. S1). Both the Arg and
Glu that make the salt link are conserved in almost all available lipoxygenase sequences.
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In the electron density map the U-shaped channel is deceptively large since the side chains
of I433 and L432 are not visible, an indication of either static or dynamic disorder.
However, even when the volume of the side chains of these amino acids is taken into
account, there is room for AA to slide into the channel and position C10 of the central
pentadiene for attack. Positively charged residues, R183 and R429, that could neutralize the
carboxylate of AA are located on both sides of the channel. Since R429 participates in the
invariant salt link described above, anchoring the arched helix (the roof of the channel) to
the helical cluster that forms the catalytic domain, it is more likely that R183 is the
neutralizing residue that positions the substrate in 8RLOX for attack at C10. Lipoxygenases
that vary with respect to positional specificity would be expected to also vary with respect to
the positions of their substrate-tethering amino acids. In contrast, the environment that
surrounds the pentadiene for H abstraction is likely to be conserved.
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L432, which points into the culvert and is positioned above the catalytic iron (Fig. 3), is
fully solvent exposed and has no side chain density past the Cβ. There is, however, sufficient
space between a Leu side chain and the catalytic iron for the Leu to secure the pentadiene
for hydrogen abstraction by Fe3+-OH. L432 is invariant in the lipoxygenase sequences
available from plants, animals and microorganisms. A role in positioning the pentadiene for
attack is consistent with this pattern of conservation. The alternative interpretation, that the
Leu is conserved because it plays an important role in the stabilization of the common
structural framework, is difficult to reconcile with the fact that the amino acid is both
solvent exposed and highly mobile, properties not generally associated with structurally
important amino acids.

Author Manuscript
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To investigate a functional role for L432, mutant enzymes with conservative substitutions
were constructed by replacement of L432 with Ala, Val, Ile or Phe. The Ala, Ile and Phe
mutations produced enzyme with less than 5% of the activity of the wild type enzyme.
While the effect of Val was less dramatic, L432V:8R-LOX still displays less than 20% wild
type activity. According to the results of kinetic experiments, this loss of activity cannot be
attributed to a loss of affinity for the substrate, as the Km for AA for the mutant enzymes is
not significantly changed from that of psWT enzyme (Table 2). Rather, the mutant enzymes
have greatly reduced turnover numbers. These data support a role in catalysis for Leu432. In
addition, about one-third of the L432F product is 12S rather than 8R, thus both the
specificity and the rate of reaction are compromised with this mutation. These results
combine to suggest that L432 plays a role in positioning and restraining the substrate
pentadiene. The reduced rates of reaction and altered product profiles can be a consequence
of the pentadiene being improperly positioned for H abstraction and/or ineffectively
restrained for oxygenation.
Mutants in I433 (I433A and I433W), a second channel-lining amino acid for which no
electron density is visible past the Cβ, were prepared in the background of the psWT. The
structures of the mutated enzymes were determined, and the effects of the mutations on
catalytic activity were evaluated. Both mutations greatly impair enzyme activity, no activity
for the I433W mutant is detected, and the I433A:psWT has measurable activity only in the
presence of CaCl2 and the detergent emolphogen.
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The crystal structures of the I433W and I433A mutant enzymes confirm that the only
structural differences induced by the mutations are localized to the immediate vicinity of the
amino acid substitution (Fig. 4). However, the two substitutions have opposite effects: the
side chains of the arched helix in the I433W:psWT structure are more ordered, while
substitution with an Ala at the same position results in disordering of the helix main chain.
In the I433W mutant there is clear density for the Trp side chain (Fig. 5) and it appears
immobilized in the U-shaped site, partially filling an otherwise solvent exposed hydrophobic
channel. The bulky Trp occupies space required for the AA tail according to our model. In
addition, the side chain of L432 is clearly visible in the I433W electron density map and
therefore no longer mobile. The replacement of I433 with a Trp appears to stabilize L432
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and plug the tail end of the proposed AA binding site. This mutant has no measurable
activity, presumably because the Trp side chain has effectively blocked the AA binding site.
In contrast, in the I433A mutant the helical arch which spans the culvert in the wild-type
enzyme is not fully defined in the electron density map: there is no density for side chains or
backbone from residues 432 to 436. It appears that the absence of the Ile side chain has
destabilized the “roof” of the U-shaped channel. This destabilization negatively impacts the
catalytic capacity of the enzyme since L432, a critical side chain according to the results
described above, is one of the residues destabilized by the mutation. This mutant produces
predominantly the 8R-product, but at a significantly impaired rate (Table 2).
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Thus mutation of amino acids that line the U-shaped channel significantly impact catalytic
activity. More importantly, the crystal structures confirm that amino acid substitutions in
this region have no structural impact outside the immediate vicinity of the mutated region.
Since both L432 and I433 are mobile and solvent-exposed in the pseudo-wild-type structure,
a structural role for these amino acids is unlikely. The observation that substitutions have
such a dramatic effect on enzyme activity are consistent with functional roles, such as
substrate positioning, for these amino acids.
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The AA binding site we propose (Fig. 3) based on the 1.85Å 8R-LOX structure is lined with
invariant amino acids in the immediate vicinity of the site that accommodates the
pentadiene. In support of our experimental results, when Evolutionary Trace(22-24) is
employed to visualize patterns of sequence conservation in lipoxygenases in a three
dimensional context, five hydrophobic amino acids lining the U-shaped channel are strictly
conserved in arachidonatemetabolizing lipoxygenases: Leu-386,391,432,628 and Ile
424.The amino acid(s) that set the register of the AA and dictate which pentadiene is
available for H abstraction should flank this area. Since LOX isoforms produce a wide array
of products, little conservation of flanking amino acids that bind the carboxylate and tail
ends of AA is predicted. Indeed, there is a lack of sequence conservation among
lipoxygenases in these regions.

DISCUSSION
The U-shaped channel contrasted with the previously described “boot-shaped” cavity
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Prior to our work the only animal LOX structure available was that of rabbit reticulocyte 15LOX in complex with the inhibitor RS7(18). Since both the U-shaped channel and the bootshaped cavity of the rabbit 15-LOX structure must provide a path for the pentadiene to
approach the catalytic iron, there is overlap between the predicted substrate binding sites. In
the two lipoxygenase models, the essential difference is that the boot-shaped cavity
protrudes past the Fe and deeper into the enzyme, whereas the U-shaped site veers back up
towards the surface. An illustration of the amino acid side chains that define the two sites is
rendered in Fig. 6. F353 in 15-LOX is proposed to form the floor of the substrate binding
site, with the bulky amino acid precluding further penetration of the AA tail. There is a
similarly positioned internal cavity in the 8R structure, but it is appreciably smaller in
volume. Yet according to the 15-LOX-derived model (25), the cavity should be larger in 8RLOX since the AA must enter 3 carbons deeper to allow the positioning of C10, rather than
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C13, at the iron coordination sphere. The positional specificity of the 8R-enzyme is
inconsistent with a smaller volume of this cavity. In contrast, the volume and details of the
U-shaped channel are consistent with a role in AA binding. The U-shaped channel is defined
by the side chains of 5 Leu and 4 Ile residues and displays remarkably high sequence
conservation (7 invariant/highly conserved in animal lipoxygenases). While there is site
directed mutagenesis data that support the boot-shaped cavity (18, 25, 26), some does not
(27). Moreover, in no case is structural data presented to evaluate the impact of the
mutations on enzyme structure. While some results may be compatible with that model, an
alternative such as the U-shaped channel cannot necessarily be ruled out.
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Partial overlap of substrate and inhibitor binding sites, as a consequence of the structural
adaptability of the ligand binding pocket, has previously been described for the structures of
the ecdysone receptor in complex with a hormone or antagonist(28). The details of the 15LOX:RS7 structure suggest that as was case for the ecdysone receptor, the inhibitor is
sufficiently dissimilar in structure from the natural substrate that it is not a true substrate/
ligand mimic. In the case of 15-LOX:RS7, two major stabilizing forces of the protein-ligand
interaction (charge-charge, aromatic-aromatic) are not relevant to the natural substrate. First,
the carboxylate of the inhibitor is neutralized by the catalytic non-heme Fe, limiting access
to the space the pentadiene must occupy for H abstraction to occur. And second, the
aromatic ring of the inhibitor, which has no counterpart in the natural substrate, is buried
deep in an aromatic cluster. Thus it may be that 15-LOX inhibitor does not fully define the
substrate binding cavity.

Author Manuscript

The recent results of photoaffinity labeling of the active site of 15-LOX are readily
explained with our U-shaped cavity extrapolated to that enzyme(29). Photo-affinity substrate
analogs with a reactive azido group at the methyl end were crosslinked to two peptides in
15-LOX. Only one peptide contains amino acids shown to be important for AA binding and
consistent with the boot-shaped cavity model (I593(25)). In contrast, when our proposed AA
binding site is modeled in 15-LOX, the binding site is flanked by the two cross-linked
peptides (Fig. 6b). Specifically, the 15-LOX counterparts of amino acids I627 and L628 are
provided by one of the peptides, while the other includes amino acids that plug the “back
door” of our channel in the 15-LOX structure (W145, K146). Importantly, while the Ushaped channel appears open at both ends in the 8R-LOX structure, this need not be the case
for other LOX isoforms. The 15-LOX structure vividly illustrates this point. While a similar
channel is apparent in the 15-LOX structure described by Choi et al. (21) the channel is
closed by the presence of W145 and a salt link (K145, D411) at one end. This closing and
consequent shortening of the channel is consistent with the fact that AA need not penetrate
as deeply into 15-LOX to position C13, rather than C10, for attack.

Author Manuscript

Comparison with Soybean Lipoxygenase L-1
As a rule, plant LOX enzymes are about 15-25 kD larger than animal enzymes, they utilize
linoleic or linolenic acids (rather than AA) as a substrate, and they share <25% sequence
identity with animal LOX. The lipoxygenase core represented by the animal enzyme
structures defines the core structure common to all lipoxygenases. Given the similarities in
terms of both protein fold and catalytic machinery of animal and plant LOX, a model that
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provides a basis for product specificity in animal enzymes should also be relevant to the
plant enzymes. Currently there are X-ray crystal structures for soybean L-1 (16, 17, 30),
which is a 13-LOX with linoleic acid and a 15-LOX with arachidonic acid, and soybean L-3
(19), which catalyzes non-specific oxygenation of fatty acids and their esters, as well as two
vegetative forms from soybean (20). There is no structure for a linoleate 9-LOX, an enzyme
predicted to hold the substrate in the opposite head-to-tail orientation (31). The amino acids
that envelop the pentadiene for attack in our model (L432, L628, and I424) are conserved in
the plant enzymes. While the counterparts of L386 and L391 are substituted with Trp and
Ala, respectively, in the plant enzymes. Although Trp narrows the channel, the
accompanying substitution of Ala for Leu appears to compensate for this loss in volume.
Klinman and co-workers(32, 33) have proposed that Leu 546 and Leu 754, the plant
counterparts to Leu 432 and Leu 628, are shielding amino acids in soybean L-1. More
recently Meyer et. al mutated I553 and found that conservative mutations dramatically
affected enzyme activity (34). I553 corresponds to V439 in 8R-LOX. This amino acid is
positioned at the C-terminal end of the arch that shelters the U-shaped channel and in our
model is a peripheral channel amino acid that helps define the substrate binding cavity.
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While there is not a channel per se apparent in the Soybean LOX structure, there is a cavity
that can be accessed with a nominal conformational change. Furthermore, a sub-cavity
which has been described as the O2 access channel (illustrated in various plant LOX
structures in a recent report (20)) appears to overlap with our U-shaped channel. The cavity
does not have access to solvent as the additional polypeptide in the plant enzymes (relative
to animal lipoxygenases) forms a β-hairpin that blocks channel access from what would
correspond to the methyl end (the “back door”) in our model, and the carboxyl end of the
putative channel is blocked by the placement of the counterpart of helix α2. Minor et al. (17)
previously suggested that T259, the counterpart of R183 on α2 in 8R-LOX, can be moved to
allow entry into the active site cavity. Helix α2 is the only helix in the LOX core that has
been described in differing positions in various LOX structures (20, 21) and this
conformational variability is consistent with the suggestion that a repositioning of this
element of secondary structure could allow entry into the internal cavity. Alternatively,
access via the “back door” of the channel would require the movement of a β-hairpin
common to the plant enzymes. There is ample precedent for such a conformational change,
and it would not require the repositioning of additional structural elements. Thus one can
envision tail-first entry from one of two possible ends of a substrate binding site that runs
under the conserved arched helix in the plant enzymes as well.
An explanation for apparently anomalous substrate specificities
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The “boot-shaped” cavity model imposes a major constraint on the physical size of
substrates that could bind in the reverse orientation as it requires that the carboxyl group is
innermost in the binding cavity. When the fatty acid substrates are provided as the
corresponding esters, the internal cavity needs to accommodate a bulkier head group.
Indeed, this criterion has been used in support of so-called “tail (methyl end)- first” versus
“head (carboxyl end)- first” entry of substrate into the active site. LOX enzymes with a
predicted “tail-first” substrate entry will specifically oxygenate not only the free fatty acid
substrate, but also very large esters such as 1-palmitoyl-2-linoleoyl-phosphatidylcholine.
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Furthermore, 5-LOX and 8S-LOX, predicted “head-first” enzymes, have not been found to
specifically oxygenate large esters.
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There are, however, notable exceptions that challenge the idea implicit in the “boot-shaped”
cavity model that the channel penetrates deep into the protein core. The plant 9-LOX are
predicted to bind substrate in the reversed orientation to 13-LOX/15-LOX enzymes.
Because the 13-LOX/15-LOX all successfully oxygenate very large esters
(phosphatidylcholine (PC), etc), in their case it is safe to place the PC moiety “outside” the
protein core during catalysis, and thus it should be “inside” for plant 9-LOX and like
enzymes. Clearly this would be hard to accommodate, and accordingly one would predict
“no reaction”. Yet plant 9-LOX do successfully metabolize some bulky esters and amides,
for example anandamide (an ethanolamide moiety) and 1-glycerol-linoleate (35, 36). These
facts are more readily reconciled with a U-shaped substrate binding mode in which (it is
predicted) the ester/amide moiety of these substrates lies “outside” the protein core at the
other end of the channel.
A new light on R versus S stereo-control
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One turn of the helix removed from L432 is G428, the amino acid that confers R-stereo
chemistry on the 8R-LOX product according to Coffa and Brash(37). Their observation that
a Gly to Ala mutation at this position results in an enzyme that produces the 12S product can
be explained in the context of the U-shaped channel. Recall that in our model AA is
positioned with its carboxyl at R183 (Fig. 3) and L432 restrains the pentadiene at the Fe. As
a consequence of its role in positioning the pentadiene for attack, L432 is also poised to
shield the pentadiene with respect to oxygenation. The wild-type enzyme produces
exclusively the 8R-product, thus L432 shields C12 from oxygenation. The presence of a C-β
at residue 428, however, would serve to push L432 away from C12 and result in the leucine
shielding C8 instead. In contrast, in the context of the boot-shaped cavity the Gly/Ala switch
presents a paradox. How does the presence of the methyl group of Ala in the R-oxygen
pocket (which is more superficial in the boot shaped cavity) redirect O2 to a pocket at the Sposition of a pentadiene (37, 38), which would lie deeper in the protein, past the catalytic
iron? In the U-shaped channel, the Ala/Gly switch is centrally positioned (i.e. there is a
single O2 pocket) where it can potentially influence either side of the reacting pentadiene,
and thus direct the oxygen molecule to the R- or S-position.
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Concluding remarks: a “general” model for substrate binding—Taken together,
the high resolution structure of 8R-lipoxygenase from Plexaura homomalla, analysis of the
impact of mutations on enzyme activity, and data in the literature, suggest a general model
for substrate binding to lipoxygenases in a U-shaped channel (Fig. 7). U-shaped channels
have been proposed to bind the substrate of other fatty acid metabolizing enzymes: the Δ9
stearoyl-acyl carrier protein desaturase (39) and soluble epoxide hydrolase (40).
The essential feature of our model is that a conserved arched helix curves over a U-shaped
channel lined with invariant leucines and isoleucines. The substrate can slide into this
channel, and wrap around the arched helix, positioning the central carbon of a pentadiene
above the catalytic iron. The conserved Leu and Ile side chains serve to guide and/or clamp
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the substrate in place and the Gly/Ala switch is positioned such that only a single oxygen
pocket is required. The LOX enzymes that utilize arachidonic acid must discriminate among
three chemically equivalent carbons. The amino acids that set the register, and thus
determine which pentadiene is attacked, are on the periphery of the U-shaped channel and
would not be expected to be conserved among lipoxygenases catalyzing different regiospecific reactions.
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Although the U-shaped channel in 8R-LOX is open at both ends, this need not be the case in
other lipoxygenase. We predict each lipoxygenase isoform is defined by a single site of
entry and that the channel is either closed at the opposite end or lacks an appropriately
positioned side chain to tether the carboxylate of the substrate. The strict regio- and stereospecificities of the LOX family members can be explained is this structural context. For
either of the two possible orientations, the substrate carboxylate would be solvent exposed,
circumventing the dilemma of “burying a charge” inherent in earlier models (41, 42). In
summary, the discovery of the U-shaped channel in 8R-LOX has allowed us to present a
new concept on substrate binding, one that is open to further evaluation in any of the
lipoxygenase enzymes.
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arachidonic acid

LOX

Lipoxygenase

8R-HPETE

8R-hydroperoxyeicosatetraenoic acid

RP-HPLC

reversed phase high pressure chromatography
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Figure 1. Regio- and stereo- specificity in lipoxygenases
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The relationship of iron-catalyzed hydrogen abstraction and oxygenation on the opposite
face of the reacting substrate. Top: with arachidonic acid in this head-to-tail orientation,
abstraction of 10-HS (proS) gives either 8R or 12S oxygenation products. Below: 10-HR
(proR) abstraction leads to 8S or 12R products.
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Figure 2. The structure of psWT, a soluble form of 8R-LOX
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(a) Cartoon rendering of the enzyme. The arched helix that shelters the catalytic Fe (orange
sphere) is shown in blue. An orange arrow indicates the location of the U-shaped channel.
(b) A cross section of the U-shaped channel which passes under the arched helix. Figures
generated with PyMOL(43) and CastP(44).
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Figure 3. The proposed AA binding site in 8R-LOX
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(a) A modeled arachidonic acid in the proposed 8R-LOX active site. The site is lined with
Leu and Ile side chains. The side chains of L432 and I433 are not visible in the electron
density map and the thinner stick rendering corresponds to the most favored rotamer for
these amino acids. Side chains identified by Evolutionary Trace(22) as invariant are in blue,
while both invariant and highly conserved resides are numbered in blue text. The only
residues unique to the 8R-enzyme are R183 and I427. The backbone of G428 is included in
stick rendering (C, yellow, O, red, N, blue), and the conserved salt link in which R429
participates is depicted (C, white; O, red; N; blue). A modeled AA is rendered as a
transparent surface (C, white; O, red). (b) A partial sequence alignment of lipoxygenases.
I424 and L432, which line the putative recognition site, are invariant, while I433 is highly
conserved. R429 is part of the invariant salt link that anchors the arched helix to the catalytic
core. The conserved G localized in the arch of the helix is indicated in red. Taxonomic
identifiers: 9CNID Cnidaria; RAT Rattus norvegicus; TETNG Tetraodon nigroviridis;
HUMAN Homo sapiens; PONPY Pongo abelii; BOVIN Bos taurus; PIG Sus scrofa;
RABIT Oryctolagus cuniculus; MOUSE Mus musculus; DANRE Danio Rerio; MESAU
Mesocricetus auratus; XENTRO Xenopus tropicalis; AT Arabidopsis thaliana; SOYBEAN,
Glycine max; TOMATO Lycopersicon esculentum.
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Figure 4. Superposition of psWT, I433W:psWT and I433A:psWT
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(a) Ribbon overlay of arched helices. There is no density for amino acids 432-436 in the
I433A;psWT structure. (psWT, gold; I433W:psWT, teal; I433A:psWT, pink) (b) Detail of
arched helix. (c) The overlay of the active sites reveals no structural differences among the
mutants. Fe is shown as a transparent sphere.
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Figure 5. A portion of an electron density map

A stereo rendering of the region of the Trp for Ile substitution in the 1.9 Å 2Fo-Fc electron
density map of I433W:psWT, contoured at 2.0σ
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Figure 6. A comparison of the boot-shaped and U-shaped sites for AA binding
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(a) Amino acids that line the proposed 15-LOX (orange) and 8R-LOX (pink) sites. The
helical arch (421-441) and helix that includes residues 367-401 are shown in tube rendering.
The RS7 inhibitor which defines the rabbit site is in red stick, the iron a dotted sphere. (b)
This view is rotated ~90° about the x-axis. Included in tube rendering (blue) are the 15-LOX
peptides that have been reported to crosslink with a photoreactive substrate analog. Note that
one of these peptides includes W145 and K145, amino acids which together with D411 (blue
stick), plug the methyl end of the channel in 15-LOX. No amino acids from this peptide line
the proposed 15-LOX binding site. (c) A stereo view of the context of the two cavities. The
view is similar to that in (b) and looking from above the enzyme as rendered in Fig. 2a.
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Figure 7. Schematic of active site features common to lipoxygenases

Invariant Leu and Ile side chains (black stick) position the pentadiene (CPK rendering) for
attack (numbered according to 8R-LOX). An invariant Leu (L432, replaced with Ala, Val,
Ile and Phe in the psWT) is donated by the arched helix that defines the roof of the active
site. The Leu is positioned to clamp the substrate in place above the Fe (red sphere). The
direction (and register) of the substrate is set by a neutralizing amino acid (R183 in the 8Renzyme) at one of the two ends of the channel.
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Data collection and refinement statistics
psWT

I433W:psWT

I433A:psWT

P21

P21

P21

            A,b,c (Å)

103.98, 170.22, 104.50

103.70, 170.21, 104.90

104.36, 170.38, 104.90

            α, β, γ (°)

90, 95.88, 90

90, 95.51, 90

90, 95.51, 90

30 – 1.85

50 – 1.90

30-2.30

Data collection
Space Group
Cell Dimensions

Resolution (Å)
Rsym

0.068 (0.677)

0.086 (0.693)

0.124 (0.660)

I/σI

21.0 (2.32)

17.1 (2.31)

12.8 (2.27)

Completeness (%)

98.8 (98.0)

98.6 (100)

100 (100)

4.0 (4.0)

4.9(5.1)

4.9(4.7)

30 – 1.85

35 – 1.90

30-2.30

Redundancy

Author Manuscript

Refinement
Resolution (Å)
No. reflections
Rwork / Rfree

287452

263905

150209

0.1740 / 0.2093

0.1591 / 0.2037

0.1675 / 0.2389

22141

22299

21805

No. atoms
    Protein
    Ligand

34

    Ion/glycerol/acetate

284

250

224

    Water

2667

2485

1582

26

27.48

27.99

    Ion/glycerol/acetate

35.68

38.13

38.8

    Water

37.26

38.31

30.84

        Bond lengths (Å)

0.015

0.016

0.023

        Bond angles (°)

1.409

1.5

1.94

B-factors
    Protein
    Ligand

43.37
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Rms Deviations

a

Values in parentheses are for the highest resolution shell

b

Rmerge = Σ | Ii -<I> | /ΣIi,where Ii is the intensity of the ith observation and <I>is the mean intensity of the reflection

c

R = Σ ∥ Fo | - | Fc ∥ / Σ |Fo |, where Fo and Fc are the observed and calculated structure factor amplitudes, respectively. Rfree was calculated

using 5% of the total reflections.
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Mutagenesis
Activity
Km (uM)

turnover (s-1)

WT

Enzyme

50± 5

206±8

        L432A

33±12

12±1

        L432F

------

trace activity

        L432I

18±4

7±1

        L432V

28± 6

42±3

*
        I433A

135± 4

19±3

        I443W

nd

nd

psWT

Author Manuscript

Regio-specificity
12 (%)

8 (%)

WT

2

98

        L432A

10

90

        L432F

34

66

        L432I

3

97

        L432V

1

99

11

89

Enzyme

psWT
        I433A
Stereochemistry

Author Manuscript

8R (%)

8S (%)

12R (%)

12S (%)

WT

100

0

10

90

        L432A

99

1

3

97

        L432F

95

5

7

94

        L432I

99

1

8

92

        L432V

100

0

----

----

95

5

16

84

psWT
        I433A
nd, not detected
*

assay conditions include 0.05% emolphogen and 2 mM CaCl2
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